Copyright
©The Author(s) 1998.
World J Gastroenterol. Oct 15, 1998; 4(5): 418-420
Published online Oct 15, 1998. doi: 10.3748/wjg.v4.i5.418
Published online Oct 15, 1998. doi: 10.3748/wjg.v4.i5.418
Cis | 5-Fu | VCR | Cis + 5-Fu | VCR + 5-Fu | Cis + VCR |
(2.5) 0.662 | (25) 0.600 | (0.25) 0.178 | (2.5 + 25) 0.709 | (2.5 + 25) 0.647 | (2.5 + 25) 0.527 |
(5.0) 0.809 | (50) 0.784 | (0.50) 0.204 | (5 + 50) 0.859 | (5 + 50) 0.713 | (5 + 50) 0.781 |
(10.0) 0.867 | (100) 0.834 | (1.00) 0.282 | (10 + 100) 0.877 | (10 + 100) 0.810 | (10 + 100) 0.844 |
(20.0) 0.893 | (200) 0.853 | (2.00) 0.429 | (20 + 200) 0.902 | (20 + 200) 0.839 | (20 + 200) 0.873 |
(40.0) 0.928 | (400) 0.871 | (4.00) 0.446 | (40 + 400) 0.951 | (40 + 400) 0.892 | (40 + 400) 0.898 |
Drug 1 (mg/L) | Drug 2 (mg/L) | fa | CI | Drug 1 (mg/L) | Drug 2 (mg/L) | fa | CI | ||||
Cis | 2.5 | 5-Fu | 100 | 0.821 | 0.75 | Cis | 2.5 | VCR | 2 | 0.554 | 1.15 |
5 | 100 | 0.856 | 0.85 | 5 | 2 | 0.858 | 0.80 | ||||
10 | 100 | 0.877 | 0.87 | 10 | 2 | 0.862 | 0.74 | ||||
20 | 100 | 0.883 | 1.09 | 20 | 2 | 0.873 | 0.71 | ||||
40 | 100 | 0.893 | 1.23 | 40 | 2 | 0.904 | 0.66 | ||||
Cis | 2.5 | 5-Fu | 200 | 0.839 | 1.85 | VCR | 0.25 | 5-Fu | 100 | 0.657 | 2.39 |
5 | 200 | 0.867 | 2.93 | 0.5 | 100 | 0.761 | 1.15 | ||||
10 | 200 | 0.899 | 2.95 | 1 | 100 | 0.810 | 0.77 | ||||
20 | 200 | 0.902 | 3.00 | 2 | 100 | 0.826 | 0.64 | ||||
40 | 200 | 0.907 | 3.36 | 4 | 100 | 0.850 | 0.51 | ||||
Cis | 2.5 | VCR | 1 | 0.498 | 0.32 | VCR | 0.25 | 5-Fu | 200 | 0.759 | 2.13 |
5 | 1 | 0.825 | 1.38 | 0.5 | 200 | 0.783 | 1.79 | ||||
10 | 1 | 0.844 | 2.05 | 1 | 200 | 0.825 | 1.28 | ||||
20 | 1 | 0.852 | 2.09 | 2 | 200 | 0.839 | 1.10 | ||||
40 | 1 | 0.894 | 3.40 | 4 | 200 | 0.867 | 0.92 |
Drugs (mg/L) | Simultaneous exposure | Pre-Cis exposure | Post-Cis exposure | |
Cis + 5-Fu | ||||
2.5 | 25 | 0.709 ± 0.015 | 0.683 ± 0.016 | 0.598 ± 0.010 |
5 | 50 | 0.859 ± 0.011 | 0.807 ± 0.027 | 0.773 ± 0.015 |
10 | 100 | 0.877 ± 0.013 | 0.824 ± 0.012 | 0.793 ± 0.026 |
20 | 200 | 0.902 ± 0.014 | 0.831 ± 0.017 | 0.805 ± 0.016 |
40 | 400 | 0.951 ± 0.012 | 0.853 ± 0.015 | 0.822 ± 0.010 |
Cis + VCR | ||||
2.5 | 0.25 | 0.527 ± 0.025 | 0.470 ± 0.023 | 0.199 ± 0.023 |
5 | 0.5 | 0.781 ± 0.034 | 0.707 ± 0.022 | 0.407 ± 0.017 |
10 | 1 | 0.844 ± 0.015 | 0.789 ± 0.025 | 0.533 ± 0.013 |
20 | 2 | 0.873 ± 0.017 | 0.818 ± 0.029 | 0.651 ± 0.021 |
40 | 4 | 0.898 ± 0.025 | 0.893 ± 0.020 | 0.752 ± 0.025 |
- Citation: Tang WX, Cheng PY, Luo YP, Wang RX. Interaction between cisplatin, 5-fluorouracil and vincristine on human hepatoma cell line (7721). World J Gastroenterol 1998; 4(5): 418-420
- URL: https://www.wjgnet.com/1007-9327/full/v4/i5/418.htm
- DOI: https://dx.doi.org/10.3748/wjg.v4.i5.418